Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PXS-5505A by Syntara for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
PXS-5505A is under clinical development by Syntara and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase...
PXS-5505A by Syntara for Scar: Likelihood of Approval
PXS-5505A is under clinical development by Syntara and currently in Phase I for Scar. According to GlobalData, Phase I drugs...
PXS-4728 by Syntara for Parkinson's Disease: Likelihood of Approval
PXS-4728 is under clinical development by Syntara and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase II...
SNT-5382 by Syntara for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
SNT-5382 is under clinical development by Syntara and currently in Phase I for Chronic Kidney Disease (Chronic Renal Failure). According...